Tiziana Life Sciences Ltd (TLSA) Earnings History
Annual and quarterly earnings data from 1998 to 2024
Loading earnings history...
TLSA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TLSA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export TLSA earnings history in CSV or JSON format
Free sign-in required to download data
Tiziana Life Sciences Ltd (TLSA) Earnings Overview
As of May 8, 2026, Tiziana Life Sciences Ltd (TLSA) reported trailing twelve-month net income of -$34M, reflecting +35.3% year-over-year growth. The company earned $-0.63 per diluted share over the past four quarters.
Looking at the long-term picture, TLSA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$272,000 in fiscal 1998.
Tiziana Life Sciences Ltd is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$464M net income), ARCT (-$66M net income, -97.9% margin), PRAX (-$327M net income), TLSA has comparable earnings metrics. Compare TLSA vs IMVT →
TLSA Earnings vs Peers
Earnings metrics vs comparable public companies
TLSA Historical Earnings Data (1998–2024)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$12M | +32.9% | -$16M | $-0.22 | - | - |
| 2023 | -$18M | -14.9% | -$18M | $-0.34 | - | - |
| 2022 | -$15M | +34.2% | -$15M | $-0.30 | - | - |
| 2021 | -$23M | +10.4% | -$27M | $-0.48 | - | - |
| 2020 | -$26M | -257.7% | -$28M | $-0.54 | - | - |
| 2019 | -$7M | -16.0% | -$8M | $-0.11 | - | - |
| 2018 | -$6M | +7.0% | -$8M | $-0.09 | - | - |
| 2017 | -$7M | +6.1% | -$8M | $-0.12 | - | - |
| 2016 | -$7M | +16.5% | -$7M | $-0.14 | - | - |
| 2015 | -$9M | -145.9% | -$9M | $-0.18 | - | - |
See TLSA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TLSA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TLSA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTLSA — Frequently Asked Questions
Quick answers to the most common questions about buying TLSA stock.
Is TLSA growing earnings?
TLSA EPS is $-0.63, with earnings growth accelerating to +35.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-34M.
What are TLSA's profit margins?
Tiziana Life Sciences Ltd net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are TLSA's earnings?
TLSA earnings data spans 1998-2024. The accelerating earnings trend is +35.3% YoY. Historical data enables comparison across business cycles.